Attanasio, R., Zarkovic, M., Papini, E., Nagy, E., Negro, R., Perros, P., Akarsu, E., Alevizaki, M., Ayvaz, G., Bednarczuk, T., Beleslin, B., Berta, E., Bodor, M., Borissova, A., Boyanov, M., Buffet, C., Burlacu, M., Ciric, J., Díez, J., Dobnig, H., Fadeyev, V., Field, B., Fliers, E., Führer, D., Galofré, J., Hakala, T., Jiskra, J., Kopp, P., Krebs, M., Krsek, M., Kuzma, M., Lantz, M., Lazúrová, I., Leenhardt, L., Luchytskiy, V., Marques Puga, F., McGowan, A., Metso, S., Moran, C., Morgunova, T., Niculescu, D., Peric, B., Planck, T., Poiana, C., Robenshtok, E., Rosselet, P., Ruchaa, M., Ryom Riis, K., Shepelkevich, A., Tronko, M., Unuane, D., Vardarli, I., Visser, W., Vryonidou, A., Younes, Y., Hegedüs, L.: Patients' persistent symptoms, clinician demographics and geo-economic factors are associated with choice of therapy for hypothyroidism by European thyroid specialists: The "THESIS"* collaboration (*Treatment of Hypothyroidism in Europe by Specialists, an International Survey).
Thyroid. [Epub ahead of print]2024.

Ratku, B., Lőrincz, H., Csiha, S., Borbásné Sebestyén, V., Berta, E., Bodor, M., Nagy, E., Szabó, Z., Harangi, M., Somodi, S.: Serum afamin and its implications in adult growth hormone deficiency: a prospective GH-withdrawal study.
Front Endocrinol (Lausanne). 15 1-13, 2024.

Csiha, S., Molnár, I., Halmi, S., Hutkai, D., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E., Berta, E., Bodor, M.: Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Front. Endocrinol. 14 1-9, 2023.

Ratku, B., Borbásné Sebestyén, V., Szelesné Árokszállási, A., Erdei, A., Berta, E., Szabó, Z., Bodor, M., Nagy, E., Somodi, S.: A felnőttkori növekedésihormon-hiány szív- és érrendszeri szövődményei.
Orv. hetil. 164 (41), 1616-1627, 2023.

Zarkovic, M., Attanasio, R., Nagy, E., Negro, R., Papini, E., Perros, P., Cohen, C., Akarsu, E., Alevizaki, M., Ayvaz, G., Bednarczuk, T., Berta, E., Bodor, M., Borissova, A., Boyanov, M., Buffet, C., Burlacu, M., Ciric, J., Díez, J., Dobnig, H., Fadeyev, V., Field, B., Fliers, E., Frlich, J., Führer, D., Galofré, J., Hakala, T., Jiskra, J., Kopp, P., Krebs, M., Krsek, M., Kuzma, M., Lantz, M., Lazúrová, I., Leenhardt, L., Luchytskiy, V., McGowan, A., Melo, M., Metso, S., Moran, C., Morgunova, T., Mykola, T., Beleslin, B., Niculescu, D., Peric, B., Planck, T., Poiana, C., Puga, F., Robenshtok, E., Rosselet, P., Ruchaa, M., Riis, K., Shepelkevich, A., Unuane, D., Vardarli, I., Visser, W., Vrionidou, A., Younes, Y., Yurenya, E., Hegedüs, L.: Characteristics of specialists treating hypothyroid patients: the "THESIS" collaborative.
Front Endocrinol (Lausanne). 14 (24), 1-11, 2023.

Csiha, S., Halmi, S., Hutkai, D., Molnár, I., Katkó, M., Lőrincz, H., Harangi, M., Paragh, G., Nagy, E., Bodor, M., Berta, E.: Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis.
EJEA. 81 EP400, 2022.

Lengyel, I., Halmi, S., Lőrincz, H., Csiha, S., Katkó, M., Harangi, M., Nagy, E., Paragh, G., Bodor, M., Berta, E.: Characterization of fetuin-A levels in patients with autoimmune thyroid disease.
Atherosclerosis. 355 e247-e248, 2022.

Berta, E., Zsíros, N., Bodor, M., Balogh, I., Lőrincz, H., Paragh, G., Harangi, M.: Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia.
Genes. 13 (7), 1-19, 2022.

Erdei, A., Gazdag, A., Ujhelyi, B., Nagy, E., Berényi, E., Berta, E., Steiber, Z., Barna, S., Mezősi, E., Bodor, M., Nagy, E.: Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy: a case report.
Eur. Thyroid J. 11 (5), 1-10, 2022.

Berta, E., Lengyel, I., Hegedűs, L., Papini, E., Perros, P., Negro, R., Attanasio, R., Nagy, E., Bodor, M.: Pajzsmirigyhormon-kezelési szokások Magyarországon.
Orv. hetil. 163 (12), 463-472, 2022.

Katkó, M., Gazdag, A., Harangi, M., Szentpéteri, A., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Bhattoa, H., Nagy, E.: The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer.
Atherosclerosis. 355 e163, 2022.

Berta, E., Bodor, M., Halmi, S., Lengyel, I., Diószegi, Á., Katkó, M., Seres, I., Nagy, E., Paragh, G., Harangi, M.: Strong correlations between serum fibroblast growth factor 21 level and lipid parameters in patients with autoimmune thyroiditis.
Atherosclerosis. 331 e201, 2021.

Katkó, M., Galgóczi, E., Erdei, A., Gazdag, A., Berta, E., Bodor, M., Seres, I., Hircsu, I., Badics, Á., Ujhelyi, B., Sira, L., Bhattoa, H., Nagy, E.: The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.
J. Inflamm. Res. 14 1883-1890, 2021.

Hircsu, I., Gazdag, A., Bodor, M., Berta, E., Andrási, M., Kanyári, Z., Győry, F., Barna, S., Bhattoa, H., Nagy, B., Nagy, E., Erdei, A.: A multiplex endokrin neoplasia-2A szindrómáról egy család kapcsán.
Orv. hetil. 161 (2), 75-79, 2020.

Galgóczi, E., Jeney, F., Katkó, M., Erdei, A., Gazdag, A., Sira, L., Bodor, M., Berta, E., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E.: Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 61 (2), 1-8, 2020.

Kovács, D., Fedor, R., Andrási, M., Barna, S., Tóth, L., Berta, E., Furka, A., Pászti, E., Damjanovich, L., Győry, F.: A differenciálatlan pajzsmirigy-carcinoma szupportív kezelésének kihívásai 3 eset bemutatása kapcsán.
Magyar Seb. 72 (3), 135, 2019.

Berta, E., Lengyel, I., Halmi, S., Puskás, I., Felszeghy, E., Balogh, Z., Nagy, E., Bodor, M.: Control of hyperglycemia in a young male patient with gigantism during transition: a case report.
Endocrine Abstracts. 63 P719, 2019.

Berta, E., Lengyel, I., Halmi, S., Zrínyi, M., Erdei, A., Harangi, M., Páll, D., Nagy, E., Bodor, M.: Hypertension in thyroid disorders.
Front Endocrinol (Lausanne). 10 1-11, 2019.

Berta, E., Bodor, M., Galuska, L., Paragh, G., Erdei, A., Gazdag, A., Ujhelyi, B., Berényi, E., Katkó, M., Gazsó, A., Nagy, E.: Early stage Graves' disease is uniformly accompanied by orbital immune activity even in patients who fail to develop orbithopathy during follow-up.
Exp. Clin. Endocrinol. Diabet. 126 (10), 628-631, 2018.

Erdei, A., Steiber, Z., Gazdag, A., Bodor, M., Berta, E., Szász, R., Szántó, A., Ujhelyi, B., Barna, S., Berényi, E., Nagy, E.: Az endokrin orbitopathia differenciáldiagnosztikája.
Orvosi Hetilap. 157 (8), 310-315, 2016.

Galgóczi, E., Jeney, F., Gazdag, A., Erdei, A., Katkó, M., M. Nagy, D., Ujhelyi, B., Steiber, Z., Győry, F., Berta, E., Nagy, E.: Cell density dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-[béta] in orbital fibroblasts.
J. Endocrinol. 229 (2), 187-196, 2016.

Berta, E., Harangi, M., Varga, V., Lórincz, H., Seres, I., Nagy, E., Paragh, G., Bodor, M.: Evaluation of serum chemerin level in patients with Hashimoto's thyroiditis.
Atherosclerosis. 252 e168, 2016.

Gazdag, A., Nagy, E., Erdei, A., Bodor, M., Berta, E., Szabó, Z., Jenei, Z.: Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
J. Endocrinol. Invest. 38 (2), 133-142, 2015.

Berta, E., Harangi, M., Zsíros, N., Nagy, E., Paragh, G., Bodor, M.: Relation between thyroid hormone status and concomitant medication in hyperlipidaemic patients with statin induced adverse effects.
Endocrine abstracts. 37 EP592, 2015.

Berta, E., Ujhelyi, B., Szabados, L., Galuska, L., Erdei, A., Gazdag, A., Halmi, S., Nagy, E., Bodor, M.: There is a detectable immune activity in the orbits of all patients diagnosed with Graves' regardless of later development of Graves' orbitopathy.
Endocrine Abstracts. 37 GP, 2015.